Basilea Raises 2026 Operating Profit Forecast to CHF 115 Million From CHF 70 Million

By Public Technologies
  • Basilea raised its 2026 operating profit forecast to about CHF 115 million from CHF 70 million.
  • Expected Cresemba and Zevtera-related revenue increased to about CHF 250 million from CHF 210 million, reflecting stronger Cresemba growth.
  • Milestone income is now projected at about CHF 65 million, up from CHF 35 million.
  • Total revenue is forecast at about CHF 310 million, representing 33% growth.
  • The 2026-2030 cumulative cash flow target from Cresemba and Zevtera rose to CHF 650 million from CHF 600 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basilea Pharmaceutica AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610270200PRIMZONEFULLFEED1001280021) on October 27, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.